Episurf Medical provides update on establishment of US commercial organisation
Episurf Medical (Nasdaq: EPIS B) today provides an update on the establishment of a US commercial organisation. In line with its strategy for the US market and its first product on the US market, the Episealer® Patellofemoral System, Episurf Medical is building a network of third-party distributors. The company has recently signed agreements with numerous third-party distributors servicing a cumulative population base of nearly 50 million people, with several more agreements expected to be signed in the coming weeks and months. Initially targeted distributors include those already doing